Advisory Committee on the Medical Uses of Isotopes; Renewal Notice, 15223-15224 [E8-5788]
Download as PDF
<![CDATA[
Federal Register / Vol. 73, No. 56 / Friday, March 21, 2008 / Notices
• Approval of February Minutes.
• Task Force Chairman’s Remarks.
• Discussion of Planned Roundtable
Discussions on Cost Sharing.
• Discussion of Web-based Survey on
Cost Sharing.
EHR Subcommittee on Science &
Engineering Indicators
Open Session: 9 a.m.–10:30 a.m.
• Approval of February Minutes.
• Chairman’s Remarks.
• Report on Luncheon Meeting with
Government-University-Industry
Research Roundtable.
• SRS Presentation on Efforts to
Develop New Data and Indicators for
Science and Engineering Indicators
2010 and Beyond.
• Additional Activities Relating to
Science and Engineering Indicators
2010.
• Presentation on Electronic ‘‘Digest’’.
• Presentation on State Data Tool.
• Chairman’s Summary.
Committee on Strategy and Budget
Open Session: 10:30 a.m.–11 a.m.
• Approval of February Minutes.
• Committee Chairman’s Remarks.
• Status Report: CSB Task Force on
Cost Sharing.
• Discussion of NSF Policies
regarding Limitations on the Number of
Proposal Submissions to a given
solicitation by a Single Institution.
CPP Subcommittee on Polar Issues
Closed Session: 11 a.m.–12 noon
• NSB Action Item: Request for
Proposal and Award of a Support
Contract for the United States Antarctic
Program.
Committee on Education and Human
Resources
Open Session: 1 p.m.–2 p.m.
• Approval of December 2007
Minutes.
• Committee Chairman’s Remarks.
• Educational Programs and the
University of Hawaii-Hilo.
• Status of Subcommittee on Science
and Engineering Indicators.
• Discussion: Preparing the Next
Generation of STEM Innovators.
• Board Executive Officer’s Report.
mstockstill on PROD1PC66 with NOTICES
Committee on Programs and Plans
Open Session: 2 p.m.–3:30 p.m.
• Approval of February Minutes.
• Committee Chairman’s Remarks.
• Status Report: Subcommittee on
Polar Issues.
fi Approval of February SOPI
Minutes.
• NSB Information Item: DataNet.
• NSB Information Item: Science of
Learning Centers (SLC) Programmatic
Update.
VerDate Aug<31>2005
18:33 Mar 20, 2008
Jkt 214001
• NSB Information Item: General
Social Survey (GSS).
• NSB Information Item: Competition
for the Management and Operation of
the National Center for Atmospheric
Research (NCAR).
• Discussion Item: Follow up to the
NSB Report to Congress on Preconstruction Funding and Maintenance
and Operations Costs Associated with
Major Research Equipment and
Facilities at the National Science
Foundation.
Committee on Programs and Plans
Closed Session: 3:30 p.m.–5 p.m.
• NSB Information Item: High
Performance Computing (HPC) Program
Updates.
• NSB Action Item: Request for
Proposal and Award of a Support
Contract for the United States Antarctic
Program.
• NSB Action Items: LIGO Operations
and Maintenance/AdvLIGO
Construction.
Executive Committee
Open Session: 5 p.m.–5:20 p.m.
• Approval of February Minutes.
• Executive Committee Chairman’s
Remarks.
• Updates or New Business from
Committee Members.
Thursday, March 27, 2008
CPP Task Force on Sustainable Energy
Open Session: 9:45 a.m.–10:15 a.m.
• Approval of February Minutes.
• Task Force Co-Chairmen’s Remarks.
• Review of February 8, 2008
Roundtable Discussion.
• Discussion of Upcoming Task Force
Activities.
Committee on Programs and Plans
Open Session: 10:15 a.m.–12 noon
• Status Report: Task Force on
Sustainable Energy.
• NSF Update on the Working Group
on Facilitating Transformative and
Interdisciplinary Research (FacTIR).
• Discussion Item: Report to Congress
on Interdisciplinary Research.
• Science Presentation: ‘‘The Breadth
of NSF Mathematical and Physical
Sciences’’.
Frm 00104
Fmt 4703
Sfmt 4703
Plenary Executive Closed
Closed Session: 1 p.m.–1:30 p.m.
• Approval of February Minutes.
• Elections for ad hoc Committee on
Nominating for NSB Elections.
• Approval of Alan T. Waterman
Award Recipient.
Plenary Closed
Closed Session: 1:30 p.m.–1:45 p.m.
• Approval of February Minutes.
• Awards and Agreements.
• Closed Committee Reports.
Plenary Session
Open Session: 1:45 p.m.–2:30 p.m.
• Approval of February Minutes.
• Resolution to Close May 2008
Meeting.
• Chairman’s Report.
• Director’s Report.
• Open Committee Reports.
Russell Moy,
Attorney-Advisor.
[FR Doc. E8–5757 Filed 3–20–08; 8:45 am]
BILLING CODE 7555–01–P
NUCLEAR REGULATORY
COMMISSION
Advisory Committee on the Medical
Uses of Isotopes; Renewal Notice
U.S. Nuclear Regulatory
Commission.
ACTION: This notice is to announce the
renewal of the Advisory Committee on
the Medical Uses of Isotopes (ACMUI)
for a period of two years.
AGENCY:
Audit and Oversight Committee
Closed Session: 8:30 a.m.–9 a.m.
• Pending Investigations.
Open Session: 9 a.m.–9:45 a.m.
• Approval of February Minutes.
• Committee Chairman’s Opening
Remarks.
• NSF Human Capital Management
Update.
• Chief Financial Officer’s Update.
• Briefing on FY 2008 Financial
Statement Audit.
PO 00000
15223
The U.S.
Nuclear Regulatory Commission (NRC)
has determined that the renewal of the
charter for the Advisory Committee on
the Medical Uses of Isotopes for the two
year period commencing on March 17,
2008 is in the public interest, in
connection with duties imposed on the
Commission by law. This action is being
taken in accordance with the Federal
Advisory Committee Act, after
consultation with the Committee
Management Secretariat, General
Services Administration.
The purpose of the ACMUI is to
provide advice to NRC on policy and
technical issues that arise in regulating
the medical use of byproduct material
for diagnosis and therapy.
Responsibilities include providing
guidance and comments on current and
proposed NRC regulations and
regulatory guidance concerning medical
use; evaluating certain non-routine uses
of byproduct material for medical use;
and evaluating training and experience
of proposed authorized users. The
SUPPLEMENTARY INFORMATION:
E:\FR\FM\21MRN1.SGM
21MRN1
15224
Federal Register / Vol. 73, No. 56 / Friday, March 21, 2008 / Notices
members are involved in preliminary
discussions of major issues in
determining the need for changes in
NRC policy and regulation to ensure the
continued safe use of byproduct
material. Each member provides
technical assistance in his/her specific
area(s) of expertise, particularly with
respect to emerging technologies.
Members also provide guidance as to
NRC’s role in relation to the
responsibilities of other Federal
agencies as well as of various
professional organizations and boards.
Members of this Committee have
demonstrated professional
qualifications and expertise in both
scientific and non-scientific disciplines
including nuclear medicine; nuclear
cardiology; radiation therapy; medical
physics; nuclear pharmacy; State
medical regulation; patient’s rights and
care; health care administration; and
Food and Drug Administration
regulation.
FOR FURTHER INFORMATION CONTACT:
Ashley Tull, Office of Federal and State
Materials and Environmental
Management Programs, U.S. Nuclear
Regulatory Commission, Washington,
DC 20555; Telephone (301) 415–5294; email Ashley.Tull@nrc.gov.
Dated: March 18, 2008.
Andrew L. Bates,
Federal Advisory Committee Management
Officer.
[FR Doc. E8–5788 Filed 3–20–08; 8:45 am]
BILLING CODE 7590–01–P
SECURITIES AND EXCHANGE
COMMISSION
Submission for OMB Review;
Comment Request
Upon Written Request, Copies Available
From: Securities and Exchange
Commission, Office of Investor
Education and Advocacy,
Washington, DC 20549–0213.
mstockstill on PROD1PC66 with NOTICES
Extension: Form 40–F, OMB Control No.
3235–0381, SEC File No. 270–335.
Notice is hereby given that, pursuant
to the Paperwork Reduction Act of 1995
(44 U.S.C. 3501 et seq.), the Securities
and Exchange Commission
(‘‘Commission’’) has submitted to the
Office of Management and Budget the
request for approval of extension of the
previously approved collection of
information discussed below.
Form 40–F (17 CFR 249.240f) is used
by certain Canadian issuers to register
securities pursuant to Section 12 of the
Securities Exchange Act of 1934
(‘‘Exchange Act’’) (15 U.S.C. 78l ) or an
VerDate Aug<31>2005
18:33 Mar 20, 2008
Jkt 214001
annual report pursuant to Section 13(a)
or 15(d) of the Exchange Act (15 U.S.C.
78m(a) or 78o(d)). The information
required under cover of Form 40–F can
be used by security holders, investors,
broker-dealers, investment banking
firms, professional securities analysts
and others in evaluating securities and
making investment decisions with
respect to securities of certain Canadian
companies. All information provided to
the Commission is available for public
review. Information provided by Form
40–F is mandatory. Form 40–F takes
approximately 427 hours per response
and is filed by approximately 205
respondents. We estimate that 25% of
the 427 hours per response (106.75
hours) is prepared by the issuer for a
total reporting burden of 21,884 (106.75
hours per response × 205 responses).
An agency may not conduct or
sponsor, and a person is not required to
respond to, a collection of information
unless it displays a currently valid
control number.
Written comments regarding the
above information should be directed to
the following persons: (i) Desk Officer
for the Securities and Exchange
Commission, Office of Information and
Regulatory Affairs, Office of
Management and Budget, Room 10102,
New Executive Office Building,
Washington, DC 20503 or send an email to
Alexander_T._Hunt@omb.eop.gov; and
(ii) R. Corey Booth, Director/Chief
Information Officer, Office of
Information Technology, Securities and
Exchange Commission, C/O Shirley
Martinson, 6432 General Green Way,
Alexandria, VA 22312; or send an email to: PRA_Mailbox@sec.gov.
Comments must be submitted to OMB
within 30 days of this notice
Dated: March 13, 2008.
Florence E. Harmon,
Deputy Secretary.
[FR Doc. E8–5675 Filed 3–20–08; 8:45 am]
BILLING CODE 8011–01–P
SECURITIES AND EXCHANGE
COMMISSION
Submission for OMB Review;
Comment Request
(44 U.S.C. 3501 et seq.), the Securities
and Exchange Commission
(‘‘Commission’’) has submitted to the
Office of Management and Budget the
request for extension of the previously
approved collection of information
discussed below.
Form CB (17 CFR 239.800) is a tender
offer statement filed in connection with
a tender offer for a foreign private
issuer. This form is used to report an
issuer tender offer conducted in
compliance with Exchange Act Rule
13e–4(h)(8) (17 CFR 240.13e–4(h)(8))
and a third-party tender offer conducted
in compliance with Exchange Act Rule
14d–1(c) (17 CFR 240.14d–1(c)). Form
CB is also used by a subject company
pursuant to Exchange Act Rule 14e–2(d)
(17 CFR 240.14e–2(d)). This information
is made available to the public.
Information provided on Form CB is
mandatory. Form CB takes
approximately .5 hours per response to
prepare and is filed by 200 issuers
annually. We estimate that 25% of the
.5 hours per response (.125 hours) is
prepared by issuer for an annual
reporting burden of 25 hours (.125 hours
per response × 200 responses).
An agency may not conduct or
sponsor, and a person is not required to
respond to, a collection of information
unless it displays a currently valid
control number.
Written comments regarding the
above information should be directed to
the following persons: (i) Desk Officer
for the Securities and Exchange
Commission, Office of Information and
Regulatory Affairs, Office of
Management and Budget, Room 10102,
New Executive Office Building,
Washington, DC 20503 or send an email to
Alexander_T._Hunt@omb.eop.gov; and
(ii) R. Corey Booth, Director/Chief
Information Officer, Securities and
Exchange Commission, C/O Shirley
Martinson, 6432 General Green Way,
Alexandria, Virginia 22312; or send an
e-mail: PRA_Mailbox@sec.gov.
Comments must be submitted to OMB
within 30 days of this notice.
Dated: March 13, 2008.
Florence E. Harmon,
Deputy Secretary.
[FR Doc. E8–5676 Filed 3–20–08; 8:45 am]
Upon Written Request, Copies Available
From: Securities and Exchange
Commission, Office of Investor
Education and Advocacy,
Washington, DC 20549–0213.
BILLING CODE 8011–01–P
Extension: Form CB, OMB Control No. 3235–
0518, SEC File No. 270–457.
Submission for OMB Review;
Comment Request
Notice is hereby given that, pursuant
to the Paperwork Reduction Act of 1995
Upon Written Request, Copies Available
From: Securities and Exchange
PO 00000
Frm 00105
Fmt 4703
Sfmt 4703
SECURITIES AND EXCHANGE
COMMISSION
E:\FR\FM\21MRN1.SGM
21MRN1
]]>Agencies
[Federal Register Volume 73, Number 56 (Friday, March 21, 2008)]
[Notices]
[Pages 15223-15224]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E8-5788]
=======================================================================
-----------------------------------------------------------------------
NUCLEAR REGULATORY COMMISSION
Advisory Committee on the Medical Uses of Isotopes; Renewal
Notice
AGENCY: U.S. Nuclear Regulatory Commission.
ACTION: This notice is to announce the renewal of the Advisory
Committee on the Medical Uses of Isotopes (ACMUI) for a period of two
years.
-----------------------------------------------------------------------
SUPPLEMENTARY INFORMATION: The U.S. Nuclear Regulatory Commission (NRC)
has determined that the renewal of the charter for the Advisory
Committee on the Medical Uses of Isotopes for the two year period
commencing on March 17, 2008 is in the public interest, in connection
with duties imposed on the Commission by law. This action is being
taken in accordance with the Federal Advisory Committee Act, after
consultation with the Committee Management Secretariat, General
Services Administration.
The purpose of the ACMUI is to provide advice to NRC on policy and
technical issues that arise in regulating the medical use of byproduct
material for diagnosis and therapy. Responsibilities include providing
guidance and comments on current and proposed NRC regulations and
regulatory guidance concerning medical use; evaluating certain non-
routine uses of byproduct material for medical use; and evaluating
training and experience of proposed authorized users. The
[[Page 15224]]
members are involved in preliminary discussions of major issues in
determining the need for changes in NRC policy and regulation to ensure
the continued safe use of byproduct material. Each member provides
technical assistance in his/her specific area(s) of expertise,
particularly with respect to emerging technologies. Members also
provide guidance as to NRC's role in relation to the responsibilities
of other Federal agencies as well as of various professional
organizations and boards.
Members of this Committee have demonstrated professional
qualifications and expertise in both scientific and non-scientific
disciplines including nuclear medicine; nuclear cardiology; radiation
therapy; medical physics; nuclear pharmacy; State medical regulation;
patient's rights and care; health care administration; and Food and
Drug Administration regulation.
FOR FURTHER INFORMATION CONTACT: Ashley Tull, Office of Federal and
State Materials and Environmental Management Programs, U.S. Nuclear
Regulatory Commission, Washington, DC 20555; Telephone (301) 415-5294;
e-mail Ashley.Tull@nrc.gov.
Dated: March 18, 2008.
Andrew L. Bates,
Federal Advisory Committee Management Officer.
[FR Doc. E8-5788 Filed 3-20-08; 8:45 am]
BILLING CODE 7590-01-P
